Evotec Investor Day Presentation Deck

evotec SMALL MOLECULES BIOLOGICS --- PAGE 72 DRUG DISCOVERY PLATFORM CELL & GENE THERAPY PRECLINICAL ANTISENSE THERAPY COMMERCIAL PRODUCT DISCOVERY Growth driven by multi-modality, integration and data surface Key growth drivers for high-impact and high-value business Capabilities and expertise creates multi-modality R&D Autobahn for growth • Biologics technology disruption "Small molecules" extension to difficult targets • Gene therapy; iPSCs and scalable cell therapy Integration drives differentiation and high value Knowledge, experience and know-how creates success loop in discovery and development (> 90% return rate of partners) • Integrated working creates quality, speed, performance and inventive steps Combination of experimental data and AI/ML surface is cutting edge • Creating and exploiting data in optimised infrastructure holds huge potential POC examples: HAL, leading with AI/ML in molecular design and predictive ADMET • Laying "data surface" onto R&D Autobahn further drives competitive advantage

View entire presentation